Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast.

Lenkinski RE, Wang X, Elian M, Goldberg SN.

Magn Reson Med. 2009 Jun;61(6):1286-92. doi: 10.1002/mrm.21937.

2.

Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.

Kousi E, Tsougos I, Vasiou K, Theodorou K, Poultsidi A, Fezoulidis I, Kappas C.

ScientificWorldJournal. 2012;2012:754380. doi: 10.1100/2012/754380. Epub 2012 May 3.

3.

Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration.

Joe BN, Chen VY, Salibi N, Fuangtharntip P, Hildebolt CF, Bae KT.

Invest Radiol. 2005 Jul;40(7):405-11.

PMID:
15973131
4.

Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.

Vassiou K, Tsougos I, Kousi E, Vlychou M, Athanasiou E, Theodorou K, Arvanitis DL, Fezoulidis IV.

Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.

PMID:
23436823
5.

Human breast lesions: characterization with proton MR spectroscopy.

Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE.

Radiology. 1998 Oct;209(1):269-75.

PMID:
9769842
6.

Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?

Baltzer PA, Gussew A, Dietzel M, Rzanny R, Gajda M, Camara O, Reichenbach JR, Kaiser WA.

NMR Biomed. 2012 Jan;25(1):67-74. doi: 10.1002/nbm.1714. Epub 2011 May 9.

PMID:
21557368
7.

The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant.

Lima EC, Otaduy MC, Tsunemi M, Pincerato R, Cardoso EF, Rosemberg S, Aguiar PH, Cerri GG, Leite CC.

AJNR Am J Neuroradiol. 2013 Jan;34(1):80-4. doi: 10.3174/ajnr.A3181. Epub 2012 Jul 5.

8.

MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma.

Geraghty PR, van den Bosch MA, Spielman DM, Hunjan S, Birdwell RL, Fong KJ, Stables LA, Zakhour M, Herfkens RJ, Ikeda DM.

Breast J. 2008 Nov-Dec;14(6):574-80. doi: 10.1111/j.1524-4741.2008.00650.x. Epub 2008 Oct 13.

9.

Quantitative multivoxel proton chemical shift imaging of the breast.

Sijens PE, Dorrius MD, Kappert P, Baron P, Pijnappel RM, Oudkerk M.

Magn Reson Imaging. 2010 Apr;28(3):314-9. doi: 10.1016/j.mri.2009.11.004. Epub 2010 Jan 13.

PMID:
20071119
10.

¹H-magnetic resonance spectroscopy of the breast at 3.0-T: comparison of results obtained before and after administration of gadolinium-based contrast agent.

Kawai H, Naganawa S, Satake H, Ishigaki S, Sakurai Y, Mori M, Maruyama K.

J Magn Reson Imaging. 2012 Mar;35(3):717-22. doi: 10.1002/jmri.22893. Epub 2011 Nov 16.

PMID:
22095613
12.

In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature.

Begley JK, Redpath TW, Bolan PJ, Gilbert FJ.

Breast Cancer Res. 2012 Apr 19;14(2):207. Review.

13.

Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.

Zhang J, Cheng K, Ding Y, Liang W, Ding Y, Vanel D, Cheng X.

Eur J Radiol. 2013 Dec;82(12):2124-8. doi: 10.1016/j.ejrad.2011.11.033. Epub 2011 Dec 12.

PMID:
22169357
14.

The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.

Dorrius MD, Pijnappel RM, van der Weide Jansen MC, Jansen L, Kappert P, Oudkerk M, Sijens PE.

Eur Radiol. 2012 Apr;22(4):915-22. doi: 10.1007/s00330-011-2322-0. Epub 2011 Nov 11.

15.

Effects of contrast material on the metabolite ratios in single-voxel MR Spectroscopy of intraaxial brain tumors.

Alkan A, Burulday V, Oztanir N, Dogan M, Erbay MF, Kocak A, Aralasmak A.

Med Hypotheses. 2012 Aug;79(2):129-31. doi: 10.1016/j.mehy.2012.03.029. Epub 2012 May 4.

PMID:
22560442
16.

MR spectroscopy of the breast.

Sardanelli F, Fausto A, Podo F.

Radiol Med. 2008 Feb;113(1):56-64. doi: 10.1007/s11547-008-0228-y. Epub 2008 Feb 25. Review. English, Italian.

PMID:
18338127
17.

Short-echo time proton MR spectroscopy in the presence of gadolinium.

Lin AP, Ross BD.

J Comput Assist Tomogr. 2001 Sep-Oct;25(5):705-12.

PMID:
11584229
18.

Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.

Baio G, Rescinito G, Rosa F, Pace D, Boccardo S, Basso L, Salvi S, Calabrese M, Truini M, Neumaier CE.

Mol Imaging Biol. 2015 Aug;17(4):548-56. doi: 10.1007/s11307-015-0823-y.

PMID:
25613673
19.

In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.

Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F.

AJR Am J Roentgenol. 2009 Jun;192(6):1608-17. doi: 10.2214/AJR.07.3521.

PMID:
19457825
20.

Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.

Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O.

Technol Cancer Res Treat. 2006 Aug;5(4):401-10.

PMID:
16866570

Supplemental Content

Support Center